Overview
- 123 inspections across 115 sites are on record.
- 219 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-12-15.
At a glance
Inspections
123
Sites
115
Observations
219
Career since
Apr 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| CSL Plasma, Inc | 15 Dec 2022 | Biologics | |
| CSL Plasma | 9 Dec 2022 | Biologics | |
| Octapharma Plasma Inc | 10 Nov 2022 | Biologics | |
| Carter BloodCare at Hulen | 28 Oct 2022 | Biologics | View 483 → |
| Biomat USA, Inc. | 14 Oct 2022 | Biologics |
Sites inspected
CSL Plasma, IncTulsa, United States1 insp.
CSL PlasmaTulsa, United States1 insp.
Octapharma Plasma IncDenton, United States1 insp.
Carter BloodCare at HulenFort Worth, United States1 insp.
Biomat USA, Inc.Carrollton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Elmina E Akwo5 shared
William F Lagud3 shared
Maira P Brading3 shared
Denise Connelly3 shared
Bobbi J Miller2 shared
Lesley Mae P Lutao2 shared
Celeta S Coves2 shared
Matthew J Gretkierewicz2 shared
Abby L Mozeke-Baker2 shared
Nobuko H Katagiri2 shared
Full investigator report
Get the verbatim findings behind Decarlos A Gomez's 219 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site